Insulin Glargine is More Suitable Than Exenatide in Preventing Muscle Loss in Non-Obese Type 2 Diabetic Patients with NAFLD

Aim This study investigated the effects of insulin glargine and exenatide on the muscle mass of patients with newly diagnosed type 2 diabetes (T2DM) and nonalcoholic fatty liver disease (NAFLD). Methods We performed a post-hoc analysis of our previously study, a 24-week randomized controlled multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lin, Wang, Ruwen, Gao, Jian, Yan, Jianhua, Zhang, Jingtian, Zhang, Zhitian, Liu, Jiaojiao, Lin, Huandong, Rao, Shengxiang, Yao, Xiuzhong, Wu, Weiyun, Bian, Hua, Wang, Xiangyu, Guo, Shanshan, Gao, Xin, Yan, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645484/
https://www.ncbi.nlm.nih.gov/pubmed/37524110
http://dx.doi.org/10.1055/a-2145-1004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645484/
https://www.ncbi.nlm.nih.gov/pubmed/37524110
http://dx.doi.org/10.1055/a-2145-1004

Ejemplares similares